Elizabeth A. O’cOnnor

Elizabeth A. O’cOnnor

Auto-generated profile, based on publicly available information

Elizabeth A. O’cOnnor

Kaiser Permanente Evidence-based Practice Center, Center for Health Research, Kaiser Permanente, Portland, Oregon

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2020 in JAMA
Verified
Journal Article
Open access
PDF file
EOElizabeth A. O’cOnnor
Elizabeth A. O’cOnnor
CECorinne V. Evans
Corinne V. Evans
MRMegan C. Rushkin
Megan C. Rushkin
NRNadia Redmond
Nadia Redmond
JLJennifer S. Lin
Jennifer S. Lin
Risk factors for cardiovascular disease (CVD), such as high blood pressure and high cholesterol and lipid levels, are common in the US and contribute to excess mortality.1 Counseling to encourage a healthy diet and physical activity in populations with CVD risk factors can improve blood pressure, cholesterol levels, and other outcomes.2 While observational evidence shows associations between lower levels of CVD risk factors and lower cardiovascular-related mortality,3-5 trial evidence regarding the effectiveness of behavioral counseling on reducing CVD events and mortality is sparse.

21 March 2015 in BMC Cancer
Verified
Journal Article
Open access
PDF file
EWElizabeth Webber
Elizabeth Webber
TKTia L Kauffman
Tia L Kauffman
EOElizabeth O’cOnnor
Elizabeth O’cOnnor
KGKatrina AB Goddard
Katrina AB Goddard
We systematically reviewed the evidence for the interaction of microsatellite instability status (MSI) and treatment with 5FU in colorectal cancer to determine how well MSI status predicts health outcomes in patients undergoing 5FU-based chemotherapy. We conducted a search of four electronic databases through June 2013. We considered studies that included both colorectal cancer patients treated with 5FU-based chemotherapy and untreated patients with survival outcomes presented by MSI status. We identified 16 studies for qualitative analysis (9,212 patients) with 14 studies eligible for meta-analysis. The microsatellite stable (MSS) group showed an effect of 5FU treatment on disease-free survival (HR of 0.62 [95% CI: 0.54, 0.71]) and overall survival (HR of 0.65 [95% CI: 0.54, 0.79]), indicating that MSS patients who received 5FU treatment had longer survival than MSS patients who were untreated. The effect of 5FU treatment was not statistically significant for microsatellite high (MSI-H) patients for disease-free survival (HR of 0.84 [95% CI: 0.53, 1.32]) or overall survival (HR 0.66 [95% CI: 0.43, 1.03]). However, the summarized point estimates of the effects of 5FU treatment for the MSS and MSI-H groups were not different at a statistically significant level. Our analyses indicate that treatment with 5FU-based chemotherapy improves disease-free and overall survival in CRC patients, but that there is no difference in the effect of treatment based on MSI status. Therefore, the use of MSI status to guide treatment decisions about the use of 5FU treatment for CRC has no significant benefits for patients.

15 April 2025 in JAMA
Verified
Journal Article
Closed access
EOElizabeth A. O’cOnnor
Elizabeth A. O’cOnnor
EWElizabeth M. Webber
Elizabeth M. Webber
AMAllea M. Martin
Allea M. Martin
MHMichelle L. Henninger
Michelle L. Henninger
MEMichelle L. Eder
Michelle L. Eder
JLJennifer S. Lin
Jennifer S. Lin
Importance: An estimated 12.8% of US households experienced food insecurity in 2022.Objective: To review the evidence on benefits and harms of screening and interventions for food insecurity in health care settings.Data Sources: MEDLINE, CINAHL, and the Cochrane Central Registry of Controlled Trials through October 11, 2022; references of existing reviews; surveillance through January 24, 2025.Study Selection: English-language randomized clinical trials (RCTs), nonrandomized studies of interventions, and pre-post studies conducted in US health care settings that examine the impact of screening or interventions for food insecurity; instrument accuracy studies of brief screening tools.Data Extraction and Synthesis: Single extraction, verified by a second reviewer. Results were narratively summarized.Main Outcomes and Measures: Food insecurity; dietary, physiologic, quality of life, health outcomes; sensitivity and specificity of screening tools.Results: One RCT (n = 789) examined the impact of screening for food insecurity and found no difference in food insecurity after 6 months (29.6% in the intervention group vs 29.8% with usual care). Ten accuracy studies (n = 123 886) compared 1-, 2-, and 6-item subsets of the US Department of Agriculture Household Food Security Survey (HFSS) with the full HFSS. Sensitivity was typically above 95% and specificity above 82%, although most studies did not administer the screener separately from the reference standard, potentially overstating the accuracy. Twenty-nine studies (n = 74 292) examined interventions to address food insecurity, but 27 were rated as poor quality for the outcomes of interest for this review. Of the 2 fair-quality studies, 1 randomized crossover study (n = 44) found that home delivery of medically tailored meals was associated with reduced food insecurity (41.9% while “on meals” vs 61.5% while “off meals,” P = .05). The other fair-quality propensity-matched cohort study found a smaller increase in body mass index among children whose families participated in a mobile food bank than those who did not after 6 months (mean difference in change, −0.68 [95% CI, −1.2 to −0.2]). The remaining studies found wide-ranging effect sizes for change in food security status but generally trended in the direction of benefit.Conclusions and Relevance: Brief screening tools likely have sufficient sensitivity to identify people with food insecurity in health care settings, but most studies of interventions to improve food insecurity had high risk of bias, limiting the ability to draw firm conclusions.

1 September 2018
Verified
Closed access
ELErin L. Leblanc
Erin L. Leblanc
CPCarrie D. Patnode
Carrie D. Patnode
EWElizabeth Webber
Elizabeth Webber
NRNadia Redmond
Nadia Redmond
MRMegan Rushkin
Megan Rushkin
EOElizabeth A. O’Connor
Elizabeth A. O’Connor

12 February 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
EOElizabeth A. O’cOnnor
Elizabeth A. O’cOnnor
CNCarrie M. Nielson
Carrie M. Nielson
APAmanda F. Petrik
Amanda F. Petrik
BGBeverly B. Green
Beverly B. Green
GCGloria D. Coronado
Gloria D. Coronado
The goal of this study was to explore diagnostic colonoscopy completion in adults with abnormal screening fecal immunochemical test (FIT) results. This was a secondary analysis of the Strategies and Opportunities to Stop Colon Cancer in Priority Populations (Stop CRC) study, a cluster-randomized pragmatic trial to increase uptake of CRC screening in federally qualified community health clinics. Diagnostic colonoscopy completion and reasons for non-completion were ascertained through a manual review of electronic health records, and completion was compared across a wide range of individual patient health and sociodemographic characteristics. Among 2,018 adults with an abnormal FIT result, 1066 (52.8%) completed a follow-up colonoscopy within 12 months. Completion was generally similar across a wide range of participant subpopulations; however, completion was higher for participants who were younger, Hispanic, Spanish-speaking, and had zero or one of the Charlson medical comorbidities, compared to their counterparts. Neighborhood-level predictors were not associated with diagnostic colonoscopy completion. Thus, completion of a diagnostic colonoscopy was relatively low in a large sample of community health clinic adults who had an abnormal screening FIT result. While completion was generally similar across a wide range of characteristics, younger, healthier, Hispanic participants tended to have a higher likelihood of completion.